首页> 外文期刊>Reumatismo >The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of fibromyalgia Best practices based on current scientific evidence
【24h】

The Italian Society for Rheumatology clinical practice guidelines for the diagnosis and management of fibromyalgia Best practices based on current scientific evidence

机译:意大利风湿病学会,基于当前科学证据的纤维肌痛诊断和管理的临床实践指导

获取原文
       

摘要

Fibromyalgia or fibromyalgia syndrome (FMS) is defined as a central sensitization syndrome characterized by the dysfunction of neurocircuits detecting, transmitting and processing nociceptive stimuli; the prevalent mani festation is musculoskeletal pain. In addition to pain, there are multiple accompanying symptoms, in common with other algo-dysfunctional syndromes, which are reflected in a broad spectrum of somatic, neurocognitive and neuro-vegetative manifestations. An evidence-based approach is essential in FMS management, in order to improve patient health and to reduce its social burden. Since in the last ten years new international guidelines for clinical practice (Clinical Practice Guidelines or CPGs) concerning FMS diagnosis and pharmacological/non-pharmacological management have been published, the Italian Society of Rheumatology (SIR) has decided to adapt them to the Italian national setting.The framework of the Guidelines International Network Adaptation Working Group was adopted to identify, appraise (AGREE II), synthesize, and customize the most recent CPGs on FMS to the needs of the Italian healthcare context. A working group of rheumatologists from SIR epidemiology unit and FMS experts identified relevant clinical questions to guide the systematic review of the literature. The target audience of these CPGs included physicians and healthcare professionals who manage FMS. The adapted recommendations were finally assessed by an external multidisciplinary panel.From the systematic search in databases (Pubmed/Medline, Embase) and grey literature, 6 CPGs were selected and appraised by two independent raters. The combination of the scientific evidence underlying the original CPGs with expert opinion lead to the development of 17 recommendations. The quality of evidence for each recommendation was reported and their potential impact on clinical practice was assessed.These SIR recommendations are expected to be a valuable aid in the diagnosis and treatment of FMS, as they will contribute to disseminate the best practice on the basis of the current scientific evidence.
机译:纤维肌痛或纤维肌痛综合征(FMS)被定义为中央致敏综合征,其特征在于神经电路检测,传播和加工伤害刺激的功能障碍;普遍的漫画乐观是肌肉骨骼疼痛。除了疼痛之外,还有多种伴随的症状,与其他算子功能障碍综合征共同,这些综合征反映在广泛的体细胞,神经认知和神经营养表现中。基于证据的方法对于FMS管理是必不可少的,以改善患者健康,并减少其社会负担。由于在过去十年内,有关FMS诊断和药理/非药理管理的新国际临床实践指南(临床实践指南或CPG)已发表,意大利风湿病学会(先生)已决定使其适应意大利国家设定。指南国际网络适应工作组的框架被采用识别,评估(同意II),综合和定制FMS上最新的CPG,以满足意大利医疗保健环境的需求。来自SIR流行病学单位和FMS专家的风湿病学家的工作组确定了指导文献系统审查的相关临床问题。这些CPG的目标受众包括管理FMS的医生和医疗保健专业人员。最终通过外部多学科面板进行了适应的建议。从数据库(PubMed / Medline,Embase)和灰色文献中系统的搜索,选择了6个CPG,并由两个独立的评估者评估。基础的科学证据与专家意见的科学证据的结合导致了17项建议的发展。报告了每个建议的证据质量,并评估了对临床实践的潜在影响。这些先生的建议预计将是对FMS诊断和治疗的宝贵援助,因为他们将有助于在基础上传播最佳实践目前的科学证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号